Figure 4: The SRB assay on MRC-5 cell lines for evaluation of
toxicity of THA in comparison to Paclitaxel
The viability of the MRC-5 cell lines treated with varying
concentrations of THA and Paclitaxel was assessed at 24, 48 and 72 hours
from treatment. The different concentrations at different time points
were carried out in triplicate.